Biofrontera Inc. to Report Third Quarter Financial Results on November 30, 2021
23. November 2021 08:15 ET
|
Biofrontera Inc.
WOBURN, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, will report financial...
Corbus Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Updates
10. November 2020 07:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Company intends to shorten fully-enrolled Phase 3 dermatomyositis trial to 28 weeks from 52 weeks following recent developments in competitive landscape; data now expected as early as the second...
Advantego Announces Third Quarter Financial Results
20. November 2019 05:00 ET
|
Advantego Corporation
Denver, CO, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Advantego Corporation (OTCQB: ADGO) today announced financial results for the third quarter ended September 30, 2019. For the third quarter, Advantego...